Skip to main content
. 2017 Dec 19;7:17805. doi: 10.1038/s41598-017-18233-w

Table 2.

Univariate analysis of OS and CSS.

Variables N OS CSS
3 year rate [95% CI] p value* 3 year rate [95% CI] p value*
Site of primary lesion oropharynx 141 0.667 [0.576–0.744] 0.685 0.723 [0.632–0.795] 0.708
hypopharynx 135 0.672 [0.574–0.752] 0.734 [0.638–0.808]
Age ≤65 years 148 0.697 [0.608–0.769] 0.066 0.759 [0.672–0.825] 0.098
>65 years 128 0.638 [0.537–0.722] 0.690 [0.589–0.771]
Gender Female 23 0.807 [0.563–0.923] 0.306 0.848 [0.596–0.949] 0.379
Male 253 0.657 [0.588–0.717] 0.717 [0.649–0.774]
KPS ≥90% 205 0.699 [0.625–0.761] < 0.001 0.752 [0.680–0.811] 0.002
<90% 71 0.582 [0.439–0.701] 0.656 [0.508–0.770]
Current smoker No 157 0.732 [0.644–0.801] 0.005 0.787 [0.701–0.851] 0.007
Yes 119 0.590 [0.490–0.677] 0.650 [0.548–0.735]
Smoking history < 10 packs year 68 0.769 [0.633–0.860] 0.012 0.829 [0.696–0.908] 0.011
≥ 10 packs year 208 0.639 [0.563–0.706] 0.697 [0.621–0.760]
T stage 123 233 0.671 [0.600–0.733] 0.031 0.736 [0.666–0.794] 0.014
4 43 0.668 [0.496–0.792] 0.690 [0.517–0.812]
N stage 0 86 0.774 [0.656–0.856] 0.054 0.869 [0.761–0.930] 0.005
123 190 0.624 [0.544–0.694] 0.666 [0.585–0.735]
Hemoglobin Concentration ≤11g/dL 31 0.612 [0.408–0.764)] 0.110 0.797 [0.572–0.912] 0.612
>11g/dL 245 0.678 [0.608–0.737] 0.721 [0.653–0.778]
CRP ≤ 0.3 mg/dl 144 0.756 [0.668–0.823] 0.005 0.801 [0.716–0.862] < 0.001
>0.3 mg/dl 132 0.575 [0.477–0.662] 0.646 [0.545–0.730]
IMRT No 223 0.676 [0.605–0.736] 0.334 0.731 [0.662–0.789] 0.445
Yes 53 0.655 [0.468–0.789] 0.728 [0.543–0.847]
Radiation fractionation Once-daily 244 0.664 [0.594–0.725] 0.704 0.730 [0.662–0.787] 0.795
Other regimen* 32 0.719 [0.515–0.849] 0.719 [0.515–0.849]
Neck dissection No 235 0.676 [0.606–0.736] 0.857 0.732 [0.663–0.788] 0.889
Yes 41 0.630 [0.432–0.775] 0.698 [0.489–0.835]
Induction chemotherapy No 182 0.645 [0.562–0.717] 0.046 0.701 [0.618–0.769] 0.139
Yes 94 0.713 [0.602–0.799] 0.776 [0.668–0.853]
Concurrent chemotherapy No 164 0.697 [0.611–0.767] 0.263 0.759 [0.675–0.824] 0.140
Yes 112 0.632 [0.527–0.720] 0.683 [0.577–0.768]

*Other regimens include twice-daily and concomitant boost radiotherapy.